Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GW-TT5
- Development stage
- Preclinical
- Lead developer
- Gateway Biotechnology
- Modality
- Wild-type AAV → AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Administration
- Intravenous, Oral
01
Overview
GW-TT5 is an investigational AAV-based gene therapy being developed by Gateway Biotechnology for the treatment of severe debilitating and chronic tinnitus. The therapy utilizes a chemogenetic approach involving Designer Receptors Exclusively Activated by Designer Drugs (DREADD). It employs an Adeno-Associated Virus (AAV) vector to deliver genetic instructions for these designer receptors specifically to inhibitory neurons within the caudate nucleus (CN) of the auditory pathway. Once expressed, these receptors can be selectively activated by a specific designer drug to modulate neuronal firing and suppress the perception of tinnitus. GW-TT5 is currently in preclinical development, with animal studies showing promise and an Investigational New Drug (IND) submission anticipated by the end of 2026.
02
Targets
hM4Di (Human muscarinic acetylcholine receptor M4 designer receptor exclusively activated by designer drugs)hM3Dq (Human muscarinic acetylcholine receptor M3 DREADD)
Beyond the preview
Go deeper on GW-TT5.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GW-TT5.